These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic. Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411 [TBL] [Abstract][Full Text] [Related]
7. The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China. Chu J; Dai Q; Dong C; Kong X; Tian H; Li C; Peng J; Xu K; Ju H; Bao C; Hu J; Zhu L Front Public Health; 2024; 12():1364048. PubMed ID: 38873290 [TBL] [Abstract][Full Text] [Related]
8. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study. Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551 [TBL] [Abstract][Full Text] [Related]
9. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study. Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786 [TBL] [Abstract][Full Text] [Related]
11. Reinfection cases by closely related SARS-CoV-2 lineages in Southern Brazil. Gularte JS; da Silva MS; Demoliner M; Hansen AW; Heldt FH; Silveira F; Filippi M; Pereira VMAG; da Silva FP; Mallmann L; Fink P; Laux JL; Weber MN; de Almeida PR; Fleck JD; Spilki FR Braz J Microbiol; 2021 Dec; 52(4):1881-1885. PubMed ID: 34562232 [TBL] [Abstract][Full Text] [Related]
12. Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak. Oliveira MM; Schemberger MO; Suzukawa AA; Riediger IN; do Carmo Debur M; Becker G; Resende PC; Gräf T; Balsanelli E; de Baura VA; de Souza EM; Pedrosa FO; Alves LR; Blanes L; Nardelli SC; Aguiar AM; Albrecht L; Zanette D; Ávila AR; Morello LG; Marchini FK; Dos Santos HG; Passetti F; Dallagiovanna B; Faoro H Virol J; 2021 Nov; 18(1):222. PubMed ID: 34789293 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico. Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF Front Public Health; 2023; 11():1149795. PubMed ID: 37181688 [TBL] [Abstract][Full Text] [Related]
14. Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2. Silva MSD; Demoliner M; Hansen AW; Gularte JS; Silveira F; Heldt FH; Filippi M; Pereira VMAG; Silva FPD; Mallmann L; Fink P; Silva LLD; Weber MN; Almeida PR; Fleck JD; Spilki FR Rev Inst Med Trop Sao Paulo; 2021; 63():e58. PubMed ID: 34231823 [TBL] [Abstract][Full Text] [Related]
15. Immune response and severity of Omicron BA.5 reinfection among individuals previously infected with different SARS-CoV-2 variants. Li L; Xie Z; Li Y; Luo M; Zhang L; Feng C; Tang G; Huang H; Hou R; Xu Y; Jia S; Shi J; Fan Q; Gan Q; Yu N; Hu F; Li Y; Lan Y; Tang X; Li F; Deng X Front Cell Infect Microbiol; 2023; 13():1277880. PubMed ID: 38188634 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023. Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 reinfection: report of two cases in Southeast Brazil. Yu ALF; Liphaus BL; Ferreira PM; Tanamachi AT; Masuda ET; Trevisan CM; Lucas PCC; Bugno A; Carvalhanas TRMP Rev Inst Med Trop Sao Paulo; 2021; 63():e50. PubMed ID: 34161556 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 reinfections in Mexico City: implications for public health. de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A Front Public Health; 2023; 11():1321283. PubMed ID: 38419814 [TBL] [Abstract][Full Text] [Related]
19. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada. Carazo S; Skowronski DM; Brisson M; Sauvageau C; Brousseau N; Gilca R; Ouakki M; Barkati S; Fafard J; Talbot D; Gilca V; Deceuninck G; Garenc C; Carignan A; De Wals P; De Serres G JAMA Netw Open; 2022 Oct; 5(10):e2236670. PubMed ID: 36239934 [TBL] [Abstract][Full Text] [Related]
20. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia. Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]